TNFRSF11B and vitiligo: Interestingly, through MR analysis, we identified TNFRSF11B, TNF alpha induced protein 3 (TNFAIP3), TNF superfamily member 12 (TNFSF12) as potentially protective factors against vitiligo, which may explain why some patients experience depigmentation after using TNF inhibitors.